Is CTY research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CTY. It does not provide personalized investment advice.

CTY (City Therapeutics, Inc. Common Stock) Stock Analysis - Financials

City Therapeutics, Inc. Common Stock (CTY) is a publicly traded the market company. As of October 20, 2026, CTY trades at $21.44 with a market cap of $1.13B and a P/E ratio of 0.00. CTY moved -4.02% today. Year to date, CTY is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $20.50 to $23.88. Rallies surfaces CTY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are CTY's key financials?

CTY financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CTY recently traded at $21.44. Market cap is $1.13B. P/E ratio is 0.00. Revenue is $0.

CTY Key Metrics

Key financial metrics for CTY
Metric	Value
Price	$21.44
Market Cap	$1.13B
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.37%
52-Week High	$23.88
52-Week Low	$20.50
Volume	279.41K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

CTY Analyst Consensus

CTY analyst coverage data. Average price target: $0.00.

Common questions about CTY

What are CTY's key financials?: CTY financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CTY recently traded at $21.44. Market cap is $1.13B. P/E ratio is 0.00. Revenue is $0.
Is CTY research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CTY. It does not provide personalized investment advice.